Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
Matteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
International Journal of Molecular Sciences
|
September 9, 2023
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?
Maura D'Amato, Monica Campagnoli, Paolo Iadarola, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Pharmaceutics
|
February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Journal of Medicinal Chemistry
|
June 9, 2026
Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation
Anshul Mishra, Wen-Bin Yang, Tsu-Shao Liu, et al.
Journal of Medicinal Chemistry
|
March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
Giulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Journal of Medicinal Chemistry
|
July 8, 2026
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>
Rasoul Tamhaev, Deborah Recchia, Monika Záhorszká, et al.
European Journal of Medicinal Chemistry
|
November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amides
Andrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
Matteo Mori, Giovanni Stelitano, Anna Griego, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
International Journal of Molecular Sciences
|
September 9, 2023
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?
Maura D'Amato, Monica Campagnoli, Paolo Iadarola, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Pharmaceutics
|
February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Journal of Medicinal Chemistry
|
June 9, 2026
Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation
Anshul Mishra, Wen-Bin Yang, Tsu-Shao Liu, et al.
Journal of Medicinal Chemistry
|
March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
Giulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Journal of Medicinal Chemistry
|
July 8, 2026
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>
Rasoul Tamhaev, Deborah Recchia, Monika Záhorszká, et al.
European Journal of Medicinal Chemistry
|
November 7, 2025
Advancing the antituberculosis activity of nitropicolinic acids and amides
Andrew M Thompson, Chen-Yi Cheung, Matthew B McNeil, et al.
Page
of 4